Identification
- Composition (DCI)
- bethamethasoneacide salicylique
- Manufacturer
- PHI
- ATC code
- D07XC01
- Presentation
- Tube de 30 g
- Schedule / Reimb.
- A
- Hospital price
- 22.00 MAD
Indications
Dermatoses corticosensibles à composante kératosique ou squameuse : 1. Indications privilégiées où la corticothérapie locale est tenue pour le meilleur traitement : · lichénification. 2. Indications où la corticothérapie est l’un des traitements habituels : · psoriasis, · lichen, · dermite séborrhéique à l’exception du visage.
Find an open pharmacy
On-call pharmacies near you
About DIPROSALIC
DIPROSALIC is marketed in Morocco by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of DIPROSALIC, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about DIPROSALIC
Answers to common questions from Moroccan patients about this drug.